Protocol No.: CO46096

A Phase III , Randomized, Open-Label, Multicenter Study Evaluating The Efficacy and Safety of Cevostamab in Combination with Pomalidomide and Dexamethasone vs SOC in Patients with Multiple Myeloma Who Have Received One to Three Prior Lines of Therapy
Principal Investigator
Veltri, Lauren
Phase
III
Age Group
Adult
Applicable Disease Site
Multiple Myeloma
Participating Institution
Mary Babb Randolph Cancer Center
Contact
Kathryn Oliverio, LPN
Research Specialist
Phone: +1 304-293-7374

View on ClinicalTrials.gov